A5029106068- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Colorectal Cancer Surgical Treatments
- Colorectal and Anal Carcinomas
- Brain Metastases and Treatment
- Lung Cancer Research Studies
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Circular RNAs in diseases
- Advanced Radiotherapy Techniques
- Management of metastatic bone disease
- Colorectal Cancer Treatments and Studies
- Cancer Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Meningioma and schwannoma management
- Colorectal Cancer Screening and Detection
- Radiation Therapy and Dosimetry
- Anorectal Disease Treatments and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Pituitary Gland Disorders and Treatments
- Radiation Dose and Imaging
- Chemotherapy-induced cardiotoxicity and mitigation
- Hepatocellular Carcinoma Treatment and Prognosis
- Lymphoma Diagnosis and Treatment
- Natural Antidiabetic Agents Studies
The Maria Sklodowska-Curie National Research Institute of Oncology
2009-2024
Centrum Onkologii
2014-2021
Fondazione FADOI
2017
Ministry of Internal Affairs of the Republic of Tajikistan
2016
Service Public Fédéral Intérieur
2016
University of Computer Sciences and Economics in Olsztyn
2016
Microsoft (Brazil)
2015
To present an interim analysis of the trial comparing two neoadjuvant therapies for unresectable rectal cancer.Patients with fixed cT3 or cT4 locally recurrent cancer without distant metastases were randomized to either 5 × Gy and 3 courses FOLFOX4 (schedule I) 50.4 delivered in 28 fractions given simultaneously 5-Fu, leucovorin oxaliplatin II). Surgery both groups was performed 12 weeks after beginning radiation 6 treatment.49 patients treated according schedule I 48 II. Grade III+ acute...
Aberrant expression of microRNAs (miRNAs) in cancer patients compared to healthy people as well possibility detection these molecules blood samples make them potential biomarkers various cancers. In the present study, we investigated role four miRNAs lung (LC) biomarkers: miRNA-448, 506, 4316, and 4478. Using quantitative reverse transcription polymerase chain reaction (qRT-PCR) technique, assessed studied plasma 90 85 individuals. Receiver operating curves (ROC) with area under curve (AUC)...
The study was conducted in the era when maintenance immunotherapy with durvalumab not available clinical practice after chemoradiotherapy (CRT) unresectable non-small-cell lung cancer (NSCLC). main aim of to check whether presence cardiovascular diseases (CVD) and their pharmacotherapy affects overall survival (OS) such NSCLC patients undergoing sequential CRT. group 196 were analyzed: 101 CVD (51.53%) 95 other reasons qualification for CRT (decreased performance status, older age,...
Background Thymic epithelial tumors constitute a morphologically and clinically diverse group of rare neoplasm the anterior mediastinum. Methods Here, we present an analysis 188 patients diagnosed with primary thymic between 1995 2015. The prognostic value selected clinical morphological factors was assessed in relation to overall survival recurrence‐free survival. Results risk recurrence increased significantly carcinoma diagnosis ( P = 0.0036), co‐occurrence other diseases, weight loss...
Concurrent chemoradiotherapy is recommended for locally advanced and unresectable non-small-cell lung cancer (NSCLC), but radiotherapy alone may be used in patients that are ineligible combined-modality therapy due to poor performance status or comorbidities, which concern elderly particular. The best candidates sequential remain undefined. purpose of the study was determine importance a patients’ age during qualification chemoradiotherapy. enrolled 196 patients. Older (age > 65years)...
The role of sequential chemoradiotherapy in non-small cell lung cancer (NSCLC) patients who are not eligible for concurrent therapy has been clearly defined. aim this study was to determine the usefulness Karnofsky performance status (KPS) monitoring and define factors determining clinical deterioration during treated from July 2009 October 2014. included 196 patients. stage defined as III A 94 (48%) B 102 (52%). Reduced KPS found 129 (65.8%). Baseline had no significant prognostic...
Venous thromboembolic events (VTE) are often diagnosed in ALK-positive lung cancer although it has not been demonstrated how their co-occurrence affects patients' survival.
Wstęp. W ostatnich 20 latach nastąpił znaczny postęp w diagnostyce i leczeniu chorych na raka piersi. Do leczenia uzupełniającego wprowadzono antracykliny taksany (AT). Celem pracy jest ocena wyników po radykalnej mastektomii radioterapii pooperacyjnej przed erą AT. Oceniono częstość występowania późnych powikłań leczenia. Materiał metody. Analizą retrospektywną objęto 470 kolejnych kobiet piersi stopniach I–III B radykalnej, napromienianych Centrum Onkologii 1985–1994. Mediana wieku...
Wstęp.Dobór leczenia uzupełniającego chorych na wczesnego raka piersi po operacji oszczędzającej zależy od wielu czynników prognostycznych, a szczególnie układu receptorów steroidowych (URS) i HER2
Material and Methods: Thirteen (13) institutions from the RCN study group among Europe United States enrolled 206 adult medulloblastoma patients who underwent postoperative RT between 1976 2014.All hospitals received their respective Institutional Review Board approval, extracted data were sent to one investigator (B.A.) for analyses.Log-rank univariate Coxmodeled multivariate analyses performed.Results: There 118 men 88 women, median age was 29 (range, 16-67).The follow-up 31 months.Tumor...
726 Background: A palliative surgery and chemotherapy is the standard of care in stage IV rectal cancer patients with pelvic symptoms. Recently we published primary results single-arm phase II study on combination short-course radiation (5x5 Gy) an oxaliplatin-based started after one-week rest (NCT01157806). The met its end-point only 17.5% (95% CI 13% to 22%) (pts) who needed stoma throughout observation 67% 58% 76%) pts having significant resolution Here provide long-term follow up data...